CompletedNot Applicable

PREVENT Pilot HPV - Related Cancers Trial

United States335 participantsStarted 2025-05-20

Plain-language summary

This study will serve as one of the first to develop and test the effectiveness of strategies to promote HPV vaccination among diverse rural parents and caregivers of children ages 9-17 years in the Mountain West. Once implemented into practice, our intervention could significantly reduce disparities in the burden of HPV-associated cancers among rural populations in the United States. The proposed study will assess the feasibility of clinic-based outreach to increase vaccination rates for HPV at four community clinics in rural counties in Washington.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Parents/Caregivers (P/C) of children/adolescents (C/A) ages 9-17 years of age (i.e., age-eligible for HPV vaccination);
✓. P/C with active clinic patients (i.e., have been seen in the clinic in the last 12 months); and
✓. P/C who speak either English or Spanish.

Exclusion criteria

✕. P/C of C/A with previous excluding HPV vaccination history (e.g., completed vaccination, or not due);
✕. P/C of C/A with clinical conditions that influence the CDC HPV vaccination recommendations (e.g., pregnancy);
✕. P/C of C/A with other factors that would influence CDC HPV recommendations; and
✕. P/C that does not speak Spanish or English.

What they're measuring

Number of Participants Correctly Randomized

Timeframe: up to 1 day after randomization

Trial details

NCT IDNCT06738355

SponsorUniversity of Utah

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-08-12

View on ClinicalTrials.gov More HPV Vaccination trials